
Grespas MF 80mg/250mg Tablet
Marketer
Lifevision Healthcare
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Grespas MF 80mg/250mg Tablet
Abdominal pain relief is provided by the combined medication, Grespas MF 80mg/250mg Tablet. This formulation effectively alleviates abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing chemical signals. Dosage and treatment duration for Grespas MF 80mg/250mg Tablets should adhere to your physician's instructions, tailored to your individual response and condition. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn; most are transient. Report any concerning side effects promptly to your doctor. Dizziness and drowsiness are potential effects; refrain from driving or mentally demanding tasks until their impact is understood. Alcohol consumption should be avoided due to potential dizziness intensification. Prior to commencing treatment, disclose any pregnancy, pregnancy planning, breastfeeding, or kidney/liver conditions to your doctor for appropriate dosage adjustment.
Primary Ingredients of Grespas MF 80mg/250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Grespas MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Grespas MF 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 80mg/250mg Grespas MF Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Grespas MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Grespas MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Grespas MF 80mg/250mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Grespas MF 80mg/250mg Tablet works:
Each Grespas MF 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Grespas MF 80mg/250mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Grespas MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Grespas MF 80mg/250mg Tablet with breastfeeding are currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Grespas MF 80mg/250mg Tablets, a potential side effect of the medication, which includes vertigo.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Grespas MF 80mg/250mg Tablets, as dose modification may be necessary. Consult a physician for guidance. Grespas MF 80mg/250mg Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Grespas MF 80mg/250mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Grespas MF 80mg/250mg Tablet :
Should you forget a dose of Grespas MF 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Grespas MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Gastrointestinal system |
